Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Myriam J. Curet, M.D. to its Board of Directors
28 Diciembre 2023 - 7:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization
of innovative, minimally invasive solutions for patients with
obstructive sleep apnea (OSA), today announced the appointment of
Myriam J. Curet, M.D., as an independent Director to its Board,
effective December 21, 2023.
“We are excited to add Dr. Curet, a practicing, board-certified
minimally invasive general surgeon with extensive business and
executive leadership experience in the medical device industry to
our Board of Directors,” said Tim Herbert, President and Chief
Executive Officer of Inspire Medical Systems. “Dr. Curet brings
significant experience in developing and commercializing scalable
solutions for minimally invasive surgery and we look forward to her
guidance, expertise and contributions to our board as we advance
Inspire therapy to treat the many patients affected by OSA.”
Dr. Curet currently serves as Executive Vice President and Chief
Medical Officer at Intuitive Surgical, a large medical device
manufacturer that develops, manufactures, and markets products that
enable physicians and healthcare providers to enhance the quality
of and access to minimally invasive care in the United States and
internationally. Dr. Curet is also Professor of Surgery at Stanford
University and previously held a faculty role at the University of
New Mexico.
Dr. Curet received her Doctor of Medicine degree from Harvard
Medical School, completed her residency in general at the
University of Chicago and completed her fellowship in surgical
endoscopy at the University of New Mexico.
In addition to Inspire, Dr. Curet serves on the boards of
Stereotaxis, a global leader in innovative robotic technologies for
the treatment of cardiac arrhythmias, and Nektar Therapeutics, a
research-based, development-stage biopharmaceutical company whose
mission is to discover and develop innovative medicines to address
the unmet medical needs of patients.
About Inspire Medical Systems
Inspire is a medical technology company focused on the
development and commercialization of innovative, minimally invasive
solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved
neurostimulation technology that provides a safe and effective
treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical facts are
forward-looking statements. Forward-looking statements involve
inherent risks and uncertainties, and important factors could cause
actual results to differ materially from those anticipated,
including the factors identified under the captions “Risk Factors”
and “Management's Discussion and Analysis of Financial Condition
and Results of Operations” in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2022 filed with the SEC, and as
such factors may be updated from time to time in our other filings
with the SEC, which are accessible on the SEC’s website at
www.sec.gov and the Investors page of our website at
www.inspiresleep.com. Forward-looking statements speak only as of
the date they are made, and we undertake no obligation to update
them in light of new information or future events.
Investor and Media ContactEzgi YagciVice
President, Investor
Relationsezgiyagci@inspiresleep.com617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024